The British Society for Antimicrobial Chemotherapy’s National OPAT Conference 2025 captured the evolution of OPAT in the ...

Depemokimab has been approved by the MHRA as the first and only biologic with twice-yearly dosing to treat asthma and severe ...

Microplastics can alter the gut microbiome, with some changes resembling patterns linked to depression and colorectal cancer, ...

Profs Carl Philpott and Claire Hopkins discuss how the MACRO trial challenges long-held assumptions about chronic ...

The 2025 ERS Congress highlighted the emerging challenges and innovations reshaping respiratory medicine, as Ravijyot Saggu ...

Significant unmet needs among people with RA-ILD have been identified in a recent survey, with clear gaps in the services ...

Clinical advantage observed in refractory atopic dermatitis with lebrikizumab plus topical corticosteroids where ciclosporin ...

Managing the future risks of type 2 diabetes and cancer in people with prediabetes should be tailored to the age of ...

Patients with chronic hand eczema often have limited effective and well-tolerated topical treatment options, a real-world ...

A newly developed 10-minute scan could improve the diagnosis and treatment of suspected primary aldosteronism, a UK pilot ...

Dr Chiara Re and Prof Grant Stewart discuss the UK’s first one-stop renal mass biopsy clinic for suspected renal cancer and ...

Regional and demographic variations persist in melanoma BRAF testing and patients with these tumours experience poorer five-year survival.